Default object view. Click to create a custom template, Node ID: 179700, Object ID: 107423

Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma

Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma

No relation

Yes

No relation

No

24/01/2017 5:34 pm

No